|
Status |
Public on Aug 26, 2022 |
Title |
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Methylation profiling by genome tiling array
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
36456881, 38837893 |
|
Submission date |
Aug 19, 2022 |
Last update date |
Sep 11, 2024 |
Contact name |
Dale W Garsed |
E-mail(s) |
dale.garsed@petermac.org
|
Organization name |
Peter MacCallum Cancer Centre
|
Street address |
305 Grattan St
|
City |
Melbourne |
State/province |
VIC |
ZIP/Postal code |
3000 |
Country |
Australia |
|
|
Platforms (4)
|
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
GPL13534 |
Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482) |
GPL21145 |
Infinium MethylationEPIC |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (262)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE211669 |
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer [RNAseq] |
GSE211686 |
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer [Methylation array] |
|
Relations |
BioProject |
PRJNA871356 |